Literature DB >> 33418977

Extracellular DNA Correlates with Intestinal Inflammation in Chemically Induced Colitis in Mice.

Martin Maronek1, Barbora Gromova1, Robert Liptak2, Barbora Konecna1, Michal Pastorek1, Barbora Cechova3, Maria Harsanyova4,5, Jaroslav Budis5,6,7, David Smolak4,5, Jan Radvanszky5,6,8, Tomas Szemes4,5,6, Jana Harsanyiova9, Alzbeta Kralova Trancikova10, Roman Gardlik1.   

Abstract

Circulating extracellular DNA (ecDNA) is known to worsen the outcome of many diseases. ecDNA released from neutrophils during infection or inflammation is present in the form of neutrophil extracellular traps (NETs). It has been shown that higher ecDNA concentration occurs in a number of inflammatory diseases including inflammatory bowel disease (IBD). Enzymes such as peptidyl arginine deiminases (PADs) are crucial for NET formation. We sought to describe the dynamics of ecDNA concentrations and fragmentation, along with NETosis during a mouse model of chemically induced colitis. Plasma ecDNA concentration was highest on day seven of dextran sulfate sodium (DSS) intake and the increase was time-dependent. This increase correlated with the percentage of cells undergoing NETosis and other markers of disease activity. Relative proportion of nuclear ecDNA increased towards more severe colitis; however, absolute amount decreased. In colon explant medium, the highest concentration of ecDNA was on day three of DSS consumption. Early administration of PAD4 inhibitors did not alleviate disease activity, but lowered the ecDNA concentration. These results uncover the biological characteristics of ecDNA in IBD and support the role of ecDNA in intestinal inflammation. The therapeutic intervention aimed at NETs and/or nuclear ecDNA has yet to be fully investigated.

Entities:  

Keywords:  PAD4; cell-free DNA; deoxyribonuclease activity; neutrophil extracellular traps; ulcerative colitis

Year:  2021        PMID: 33418977     DOI: 10.3390/cells10010081

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  6 in total

Review 1.  The emerging role of neutrophilic extracellular traps in intestinal disease.

Authors:  Feng Chen; Yongqiang Liu; Yajing Shi; Jianmin Zhang; Xin Liu; Zhenzhen Liu; Jipeng Lv; Yufang Leng
Journal:  Gut Pathog       Date:  2022-06-22       Impact factor: 5.324

Review 2.  Imaging Inflammation - From Whole Body Imaging to Cellular Resolution.

Authors:  Tuula Peñate Medina; Jan Philip Kolb; Gereon Hüttmann; Robert Huber; Oula Peñate Medina; Linh Ha; Patricia Ulloa; Naomi Larsen; Arianna Ferrari; Magdalena Rafecas; Mark Ellrichmann; Mariya S Pravdivtseva; Mariia Anikeeva; Jana Humbert; Marcus Both; Jennifer E Hundt; Jan-Bernd Hövener
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

Review 3.  The Citrullination-Neutrophil Extracellular Trap Axis in Chronic Diseases.

Authors:  Martin Maronek; Roman Gardlik
Journal:  J Innate Immun       Date:  2022-03-09       Impact factor: 7.111

4.  Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets.

Authors:  Huiwen Che; Tatjana Jatsenko; Lore Lannoo; Kate Stanley; Luc Dehaspe; Leen Vancoillie; Nathalie Brison; Ilse Parijs; Kris Van Den Bogaert; Koenraad Devriendt; Sabien Severi; Ellen De Langhe; Severine Vermeire; Bram Verstockt; Kristel Van Calsteren; Joris Robert Vermeesch
Journal:  NPJ Genom Med       Date:  2022-09-14       Impact factor: 6.083

5.  Hypercholesterolemia promotes autoantibody production and a lupus-like pathology via decreased DNase-mediated clearance of DNA.

Authors:  Umesh Kumar Dhawan; Andreas Margraf; Maciej Lech; Manikandan Subramanian
Journal:  J Cell Mol Med       Date:  2022-09-13       Impact factor: 5.295

Review 6.  Neutrophil Extracellular Traps in Colorectal Cancer Progression and Metastasis.

Authors:  Umama Khan; Sabrina Chowdhury; Md Morsaline Billah; Kazi Mohammed Didarul Islam; Henrik Thorlacius; Milladur Rahman
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.